Inside Nephrology: A Weekly Review
Nefrologia
Inflammation, Genetics, and Hidden Links: Rethinking Chronic Kidney Disease
From inflammatory pathways to genetic markers and overlooked screening gaps, this episode explores the latest research reshaping how we detect and treat chronic kidney disease.
Bibliography
- Hanaoka H, et al. Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis. Immunol Med. 2025;48(3):161-170.
- Saltarocchi S, et al. Chronic kidney disease and valvular heart disease: state of the art. Physiol Rep. 2025;13(18):e70544.
- Lin CJ, et al. Fabry disease screening, diagnosis and management in CKD: expert consensus. J Formos Med Assoc. 2025;124(9):794-799.
- Taub PR, et al. Finerenone in CKD-type 2 diabetes and heart failure prevention. Heart Fail Rev. 2025;30(5):971-984.
- He X, Li H. LncRNA in pathogenesis, diagnosis and treatment of chronic kidney disease. Cell Biochem Biophys. 2025;83(3):2703-2711.
- Bakker WM, et al. Renal Lifecycle trial of dapagliflozin in severe CKD: rationale and design. Nephrol Dial Transplant. 2025;40(9):1746-1755.
- Watanabe S, et al. Lubiprostone in CKD: mitochondrial function and polyamines, phase 2 trial. Sci Adv. 2025;11(35):eadw3934.
- Ketema DB, et al. Quality of care in chronic kidney disease: systematic review and meta-analysis. BMJ Open. 2025;15(9):e102044.
- Bui KL, et al. eHealth solutions for symptom assessment and monitoring in adults with CKD: systematic review. J Clin Nurs. 2025;34(9):3560-3591.
- Moriyama T, et al. Diagnostic status of CKD in Japan: CHECK-CKD real-world database. Clin Exp Nephrol. 2025;29(9):1212-1222.
